ANDA 75526, held by Sun Pharm Inds Inc. Ticlopidine Hydrochloride.
As of Nov 16, 2026, ANDA 75526 (Ticlopidine Hydrochloride), held by Sun Pharm Inds Inc, was first approved by FDA on Sep 26, 2002, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 26, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ticlopidine Hydrochloride250MG · tablet;oral | Ticlopidine Hydrochloride | Discontinued |
| Sep 11, 2015 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jan 31, 2003 | Supplement 2Labeling | Approved | None posted |
| Sep 26, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters